---
title: Disclosure of shareholding
description: Disclosure of shareholding
---

Viola AS, a wholly-owned subsidiary of Rasmussengruppen AS, acquired 150,000 shares in Gentian Diagnostics ASA (the "Company") on 14 December 2023 with settlement on 18 December 2023.

As a result of the transaction, companies wholly-owned by Rasmussengruppen AS increased their consolidated holding of shares in the Company from 705,916 to 855,916 shares, equal to an increase from approximately 4.58% to approximately 5.55% of the votes and shares in the Company. The shares are held by Viola AS (320,916 shares), Portia AS (300,000 shares) and Cressida AS (235,000).

The above mentioned companies have no other rights to shares issued by the Company.

This announcement is made in accordance with Section 4-2 of the Norwegian Securities Trading Act.

### You may also read

[Jul 02, 2026 - Ole Sørlie](https://www.gentian.com/investor-relations-stock-information/investors-news/disclosure-of-shareholding#)

##### [Gentian Diagnostics: Invitation to presentation of second quarter results](https://www.gentian.com/investor-relations-stock-information/investors-news/gentian-diagnostics-invitation-to-presentation-of-second-quarter-results-1)

Gentian Diagnostics ASA will present its second quarter 2026 results on 9 July 2026 at 09.00 CEST. The..

[Read more](https://www.gentian.com/investor-relations-stock-information/investors-news/gentian-diagnostics-invitation-to-presentation-of-second-quarter-results-1)

[Jun 24, 2026 - Ole Sørlie](https://www.gentian.com/investor-relations-stock-information/investors-news/disclosure-of-shareholding#)

##### [ESSANGE REAGENTS AND GENTIAN DIAGNOSTICS ANNOUNCE COLLABORATION AGREEMENT](https://www.gentian.com/investor-relations-stock-information/investors-news/essange-reagents-and-gentian-diagnostics-announce-collaboration-agreement)

Amsterdam / Moss, 24 June 2026 ESSANGE REAGENTS AND GENTIAN DIAGNOSTICS ANNOUNCE COLLABORATION AGREEMENT..

[Read more](https://www.gentian.com/investor-relations-stock-information/investors-news/essange-reagents-and-gentian-diagnostics-announce-collaboration-agreement)

[May 29, 2026 - Ole Sørlie](https://www.gentian.com/investor-relations-stock-information/investors-news/disclosure-of-shareholding#)

##### [Mandatory notification of trade](https://www.gentian.com/investor-relations-stock-information/investors-news/mandatory-notification-of-trade-1780055230560)

Moss, 29 May 2026 Gentian Diagnostics ASA ("Gentian") has today been notified that the following transaction..

[Read more](https://www.gentian.com/investor-relations-stock-information/investors-news/mandatory-notification-of-trade-1780055230560)